Literature DB >> 18291308

The health benefits of calcium citrate malate: a review of the supporting science.

Susan Reinwald1, Connie M Weaver, Jeffrey J Kester.   

Abstract

There has been considerable investigation into the health benefits of calcium citrate malate (CCM) since it was first patented in the late 1980s. This chapter is a comprehensive summary of the supporting science and available evidence on the bioavailability and health benefits of consuming CCM. It highlights the important roles that CCM can play during various life stages. CCM has been shown to facilitate calcium retention and bone accrual in children and adolescents. In adults, it effectively promotes the consolidation and maintenance of bone mass. In conjunction with vitamin D, CCM also decreases bone fracture risk in the elderly, slows the rate of bone loss in old age, and is of benefit to the health and well-being of postmenopausal women. CCM is exceptional in that it confers many unique benefits that go beyond bone health. Unlike other calcium sources that necessitate supplementation be in conjunction with a meal to ensure an appreciable benefit is derived, CCM can be consumed with or without food and delivers a significant nutritional benefit to individuals of all ages. The chemistry of CCM makes it a particularly beneficial calcium source for individuals with hypochlorydia or achlorydia, which generally includes the elderly and those on medications that decrease gastric acid secretion. CCM is also recognized as a calcium source that does not increase the risk of kidney stones, and in fact it protects against stone-forming potential. The versatile nature of CCM makes it a convenient and practical calcium salt for use in moist foods and beverages. The major factor that may preclude selection of CCM as a preferred calcium source is the higher cost compared to other sources of calcium commonly used for fortification (e.g., calcium carbonate and tricalcium phosphate). However, formation of CCM directly within beverages or other fluid foods and/or preparations, and the addition of a concentrated CCM solution or slurry, are relatively cost-effective methods by which CCM can be incorporated into finished food and beverage products.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18291308     DOI: 10.1016/S1043-4526(07)00006-X

Source DB:  PubMed          Journal:  Adv Food Nutr Res        ISSN: 1043-4526


  7 in total

1.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

2.  Cloning and Characterization of a Pyruvate Carboxylase Gene from Penicillium rubens and Overexpression of the Genein the Yeast Yarrowia lipolytica for Enhanced Citric Acid Production.

Authors:  Ge-Yi Fu; Yi Lu; Zhe Chi; Guang-Lei Liu; Shou-Feng Zhao; Hong Jiang; Zhen-Ming Chi
Journal:  Mar Biotechnol (NY)       Date:  2016-02       Impact factor: 3.619

Review 3.  Do Calcium Supplements Predispose to Urolithiasis?

Authors:  Diomidis Kozyrakis; Dionysios Paridis; Anastasios Karatzas; Georgios Soukias; Zoi Dailiana
Journal:  Curr Urol Rep       Date:  2017-03       Impact factor: 3.092

Review 4.  Calcium revisited: part II calcium supplements and their effects.

Authors:  Olivier Lamy; Peter Burckhardt
Journal:  Bonekey Rep       Date:  2014-10-08

5.  A longitudinal study of the effect of genistein on bone in two different murine models of diminished estrogen-producing capacity.

Authors:  Susan Reinwald; Loretta P Mayer; Patricia B Hoyer; Charles H Turner; Stephen Barnes; Connie M Weaver
Journal:  J Osteoporos       Date:  2009-10-18

Review 6.  Calcium in Gluten-Free Life: Health-Related and Nutritional Implications.

Authors:  Urszula Krupa-Kozak; Natalia Drabińska
Journal:  Foods       Date:  2016-07-15

7.  Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial.

Authors:  E V Souza; M R Torloni; A N Atallah; G M S dos Santos; L Kulay; N Sass
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.